Altamira Therapeutics Ltd - Warrants (29/03/2028) Profit Margin

As of the most recent data (June 2023), CYTOW shows a profit margin of 4482.79%. That compares with -2810.27% in the prior-year period — up 259.5% year over year. That is above the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTOW's profit margin is now 4482.79% (was -2810.27%) — a 259.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Altamira Therapeutics Ltd - Warrants (29/03/2028) is outperforming or lagging.

The Healthcare sector average profit margin is about 14.34%. Altamira Therapeutics Ltd - Warrants (29/03/2028) is at 4482.79%, which is higher that average. That is roughly 31150.4% above the sector mean. Use the comparison chart on this page to see how CYTOW stacks up against individual peers as well.

That compares with -2810.27% in the prior-year period — up 259.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Altamira Therapeutics Ltd - Warrants (29/03/2028) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Altamira Therapeutics Ltd - Warrants (29/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 4482.79%) with ownership activity and broader fundamentals.